|
|
|
|
Vol. 55, Issue 2, 210-215, February 1999
Institut de Pharmacologie Moléculaire et Cellulaire, Unité Propre de Recherche 411, Centre National de la Recherche Scientifique, Valbonne, France
| |
Summary |
|---|
|
|
|---|
The highly conserved aspartate residue in the second transmembrane
domain of G protein-coupled receptors is present in position 113 in the
type 1 neurotensin receptor (NTR1) but is replaced by an Ala residue in
position 79 in the type 2 neurotensin receptor (NTR2). NTR1 couples to
G
q to stimulate phospholipase C and its binding affinity for
neurotensin is decreased by sodium ions and GTP analogs. By contrast,
NTR2 does not seem to couple to any G protein in eukaryotic cells, and
its binding of neurotensin is insensitive to sodium and GTP analogs. By
using site-directed mutagenesis, we substituted Asp113 of the NTR1 by
alanine and the homologous residue Ala79 of NTR2 by aspartate. Both
mutant receptors display similar affinity for neurotensin as compared with their respective wild type. We demonstrate that the presence of
the Asp residue determines by itself the occurrence of the sodium
effect on neurotensin affinity for both wild-type and mutated NTR1 and
-2. The introduction of an Asp in the second transmembrane domain of
NTR2 is not enough to restore a functional coupling to G proteins. In
contrast, replacement of Asp113 by Ala residue in NTR1 strongly
decreases its ability to activate inositol turnover, indicating that
the functionally active conformation of NTR1 is maintained by
interaction of sodium ions with aspartate 113.
| |
Introduction |
|---|
|
|
|---|
Several
guanine nucleotide-binding protein (G protein)-coupled receptors are
sensitive to Na+ ions that reduce their affinity
for agonists (Ceresa and Limbird, 1994
). Site-directed mutagenesis
studies have identified a highly conserved Asp residue in the second
transmembrane (TM) spanning domain as the site of
Na+ regulation of agonist binding (Neve et al.,
1991
; Kong et al., 1993a
,b
; Quintana et al., 1993
; Ceresa and Limbird,
1994
). Mutant receptors obtained from these studies can be classified
into two categories. For the first class of Asp mutant receptors,
such as those of alpha-2 and beta adrenergic
receptors (Neve et al., 1991
; Ceresa and Limbird, 1994
), agonist
binding was no longer regulated by GTP analogs, indicating that
mutation of the Asp residue disturbs receptor-G protein interactions. A
second class of Asp mutant receptors such as the sst2 receptor remained
sensitive to GTP analogs (Kong et al., 1993a
), indicating a different
mode of interaction of these receptors with G proteins.
The two neurotensin receptors (NTR) cloned to date (Tanaka et al.,
1990
; Vita et al., 1993
; Mazella et al., 1996
; Chalon et al., 1996
)
represent an excellent model to study NT binding regulation by
Na+. Indeed, the type 1 NT receptor (NTR1)
bears the highly conserved Asp residue in the second TM domain and
binding to NT is sensitive to Na+ ions and GTP
analogs. Moreover, the NTR1 is functionally coupled to phospholipase C
when stably expressed in CHO or LTK cells (Hermans et al., 1992
; Watson
et al., 1992
; Chabry et al., 1994
). By contrast, the NTR2 (Mazella et
al., 1996
, Chalon et al., 1996
) is characterized by the absence in its
sequence of the Asp residue in TM II, the corresponding position being
occupied by an alanine. Interestingly, the binding of NT to this
receptor type is insensitive to physiological concentrations of
Na+ (IC50
200 mM) and to
GTP analogs (Mazella et al., 1996
). The NTR2 does not seem to interact
with classical G proteins, because no coupling was observed in HEK
cells stably transfected with the mouse NTR2 cDNA (Botto et al. 1998
).
The purpose of the present work was to assess the importance of the
conserved Asp residue in the regulation of NT binding to its receptors
by Na+ ions and GTP. Using site-directed
mutagenesis, we replaced the Asp113 residue of the rat NTR1 by the
corresponding Ala residue of the NTR2 and incorporated an aspartate
instead of alanine in position 79 in the NTR2 sequence. The effect of
Na+ ions and
guanosine-5'-O-(
-thio)triphosphate (GTP
S) on NT
binding properties were studied for mutant receptors and compared with those of native receptors. We show that the presence of an aspartate in
the TM II is an absolute requirement for the effect of
Na+ but not for the effect of the GTP analog.
| |
Materials and Methods |
|---|
|
|
|---|
Materials.
NT was purchased from Peninsula Laboratories
(Belmont, CA) and 125I-labeled Tyr3-NT was
prepared and purified as previously described (Sadoul et al., 1984
).
The pcDNA3 expression vector was purchased from Invitrogen (San Diego,
CA), Dulbecco's modified Eagle's medium and gentamycin were purchased
from Life Technologies (Gaithersburg, MD). Fetal calf serum was
purchased from Boehringer Mannheim (Indianapolis, IN), and
oligodeoxynucleotides and restriction or modification endonucleases
were from Eurogentec (Seraing, Belgium). Taq polymerase was from Appligene (Appligene Oncor, Illkirch, France).
Mutant NT Receptor Construction and Expression.
The
HindIII-NotI fragment (1.45 kb) of the
rat NTR1 cDNA and the HindIII-ApaI
fragment (1.5 kb) of the mouse NTR2 cDNA were subcloned into the pcDNA3
expression vector. Site-directed mutagenesis was performed by
polymerase chain reaction according to the method of Jones et al.
(1990)
using oligodeoxynucleotides bearing the point mutation. The
introduction of mutations in the receptor cDNAs was confirmed by
sequencing with the dye terminator ABI PRISM sequencing kit
(Perkin-Elmer, Norwalk, CT) using appropriate oligodeoxynucleotidic primers.
Binding Studies.
Binding experiments were carried out on
freshly prepared cell homogenates as previously described (Chabry et
al., 1994
). Competition experiments were initiated by incubation of
cell homogenates (10 µg for NTR1-transfected cells and 50 µg for
NTR2-transfected cells) in 250 µl of binding buffer: 50 mM Tris-HCl,
pH 7.5, containing 0.1% bovine serum albumin, 1 mM MgCl2,
and 0.8 mM 1-10 phenanthroline (metallopeptidase inhibitor) with 0.4 nM
125I-labeled Tyr3-NT (2000 Ci/mmol) (Sadoul et
al., 1984
) and increasing concentrations of unlabeled NT or GTP
S
(from 10
10 to 10
6 M).
Saturation experiments were performed by competition assay in which the
binding of 0.4 nM 125I-labeled Tyr3-NT (2000 Ci/mmol) was inhibited by increasing concentrations of unlabeled NT
(0.2-50 nM). We have previously demonstrated that iodinated and
unlabeled peptides bound NT receptors with the same affinity (Sadoul et
al., 1984
). The nonspecific binding was determined in parallel
experiments in the presence of 1 µM unlabeled NT. After 20 min at
25°C, incubation media were filtered through cellulose acetate
filters (Sartorius, Bohemia, NY). Filters were rinsed twice with 2 ml
of ice-cold binding buffer and counted in a Packard gamma counter. The
effect of Na+ ions on 125I-labeled
Tyr3-NT binding was measured with NaCl concentrations ranging from 3 to 300 mM. In some cases, competition experiments with
unlabeled NT were performed in the presence of 15 or 50 mM Na+.
Phosphoinositides (PI) Determination.
Twenty four hours
after transfection with different NT receptor forms, cells were grown
in 12-well plates for 15 to 18 h in the presence of 1 µCi of
[3H]myo-inositol (ICN Biomedicals, Ovsay, France)
in a serum-free Ham's-F10 medium. Cells were washed with Earle's
buffer, pH 7.5, (25 mM HEPES, 25 mM Tris, 140 mM NaCl, 5 mM KCl, 1.8 mM
CaCl2, 0.8 mM MgCl2, and 5 mM glucose)
containing 0.1% bovine serum albumin, and incubated for 15 min at
37°C in 900 µl of 30 mM LiCl in Earle's buffer. NT was then added
at the indicated concentrations for 15 min. The reaction was stopped by
750 µl of ice-cold 10 mM HCOOH, pH 5.5. After 30 min at 4°C, the
supernatant was collected and neutralized by 2.5 ml of 5 mM
NH4OH. Total [3H]PI were separated from free
[3H]inositol on Dowex AG-X8 (Bio-Rad, Hercules, CA) (Van
Renterghem et al., 1988
) chromatography by eluting successively with 5 ml of water and 4 ml of 40 mM and 1 M ammonium formate, pH 5.5. The radioactivity contained in the 1 M fraction was counted after addition
of 5 ml of Ecolume (ICN Biomedicals).
| |
Results |
|---|
|
|
|---|
The TM II Asp residue conserved in most of the G protein-coupled
receptors is present in position 113 in the sequence of the NTR1 and
substituted by Ala79 in the NTR2 (Fig.
1). This amino acid was replaced on each
receptor by the homologous residue of the other. We then compared the
binding properties and sensitivity to Na+ ions
and GTP
S as well as the coupling efficiency of the mutant receptors
to those of the wild-type receptors.
|
Compared Affinities of Mutant and Wild-Type NT Receptors Toward NT. Competition binding experiments between 125I-labeled Tyr3-NT and unlabeled NT were performed on membrane homogenates from COS-7 cells transiently transfected with recombinant plasmids of the wild-type and mutated NTR1 and NTR2. Figure 2 shows that the affinity of the D113A NTR1 mutant for NT (IC50 = 0.8 ± 0.15 nM, n = 3) was not significantly altered when compared with that of the wild-type receptor (IC50 = 0.6 ± 0.2 nM, n = 4) (Fig. 2A). The IC50 value of the A79D NTR2 mutant was only slightly higher (IC50 = 2 ± 0.3 nM, n = 3) than that of the wild-type NTR2 (IC50 = 1.5 ± 0.4 nM, n = 4) (Fig. 2B), indicating that the affinity of the A79D-NTR2 mutant was not significantly different from that of the native NTR2.
|
Effect of Sodium Ions on Binding of Mutant and Wild-Type NT Receptors. The binding of 0.4 nM 125I-labeled Tyr3-NT to homogenates of cells transfected with the wild-type NTR1 receptor was inhibited in a concentration-dependent manner by Na+ (Fig. 3 A) with a half-maximal inhibiting concentration (IC50) of 17.7 ± 2.2 mM (n = 4). Substitution of the Asp113 residue by an alanine decreased the sensitivity of the mutated NTR1 to Na+ ions by a factor of 10 (IC50 = 144 ± 11 mM, n = 4) (Fig. 3A).
|
|
Effect of GTP
S on Binding of Mutant and Wild-Type NT
Receptors.
As previously shown, GTP analogs modulate the affinity
of NT for the rat and human NTR1 stably transfected in LTK or CHO cells (Chabry et al., 1994
; Watson et al., 1992
). This effect was correlated with the coupling efficiency of this receptor type to phospholipase C
and adenylate cyclase. By contrast, the absence of coupling observed
for the mouse NTR2 stably expressed in HEK cells was associated with
the absence of GTP
S effect on NT binding (Botto et al., 1998
).
S on NT binding to membrane homogenates
from cells transfected with mutant and wild-type NT receptors (Fig.
5). The binding of 125I-labeled Tyr3-NT to
D113A mutant and wild-type NTR1 was inhibited in a
concentration-dependent manner by GTP
S (Fig. 5). A maximal inhibition of about 65 to 75% was observed with an
IC50 of 3 ± 0.7 nM (n = 4)
for both type 1 NT receptors. By contrast, the binding of
125I-labeled Tyr3-NT to
membranes from cells expressing either the A79D mutant or the wild-type
NTR2 was not affected by GTP
S independently of the presence or the
absence of the Asp residue in the TM II (Fig. 5).
|
Agonist-Stimulated PI Turnover.
NT-stimulated PI production
was measured in COS-7 cells expressing either the wild-type NTR1 and
NTR2 or D113A-NTR1 and A79D-NTR2 mutants. Figure
6 shows that none of the NTR2 forms were
able to increase PI production upon NT stimulation. In contrast, both the wild-type and the D113A mutant of NTR1 stimulated PI levels as a
function of NT concentration (Fig. 6). However, although these two
receptor forms displayed identical NT binding sensitivity to GTP
S
(Fig. 5), NT was 100-fold less potent on the D113A-NTR1 (EC50 = 10.3 ± 2.3 nM, n = 3)
than on the wild-type NTR1 (EC50 = 0.09 ± 0.01 nM,
n = 3) (Fig. 6). This difference in the potency of
NT to stimulate PI production is not due to the differential receptor
expression between the wild-type NTR1 (Bmax = 920 ± 150 fmol/mg, n = 5) and the
D113A-NTR1 (Bmax = 200 ± 23 fmol/mg,
n = 3). Indeed, when the expression of the
wild-type is lowered to the amount of mutant by transfection with 0.2 µg of recombinant plasmid, the potency of NT remains quite identical,
although the amount of [3H]PI accumulation is three times
lower (Fig. 6).
|
| |
Discussion |
|---|
|
|
|---|
This work demonstrates that the presence of the Asp residue in the second TM of NTR1 and NTR2 is critical for the modulation of their affinities by Na+ ions. This negatively charged residue is also necessary for an efficient coupling of the NTR1 to phospholipase C.
The absence of efficient coupling to phospholipase C for the NTR2
stably expressed in eukaryotic cell system (Botto et al., 1998
) was
initially correlated with its insensitivity to physiological concentrations of Na+ ions
(IC50 = 250 mM) (Mazella et al., 1996
). We
hypothesized that this property was the consequence of the absence of
an highly conserved Asp residue in the second TM spanning domain of the NTR2, the corresponding position being occupied by an alanine residue.
The substitution of this alanine by an Asp residue (A79D-NTR2) effectively reconstituted a relatively good sensitivity of the type 2 NT receptor to Na+ ions
(IC50 = 55 mM), and we verified that this
sensitivity was due to a decrease of the affinity for NT in the
presence of Na+ ions. However, the A79D mutant
NTR2 remained uncoupled to phospholipase C when expressed into COS-7
cells. The lack of coupling for both the wild-type NTR2 and the
A79D-NTR2 mutant was in agreement with their insensitivity to GTP
S
(Fig. 5) and their inability to increase the PI turnover in response to
NT (Fig. 6). These data indicate that the ability of NTR2 to couple to
G proteins does not depend solely upon the presence of an Asp residue
in its second TM domain.
The NTR1 belongs to the family of G protein-coupled receptors in which
the Asp residue (D113), located in the second TM domain, is strictly
conserved (Probst et al., 1992
). The affinity of the NTR1 for NT was
therefore classically regulated by Na+ ions
(IC50 = 17.7 mM) and by GTP
S
(IC50 = 3 nM). The NTR1 expressed in COS-7 cells
responded to NT by a dose-dependent accumulation of IPs with an
EC50 of about 0.1 nM and this whatever the amount of expressed receptors (Fig. 6). The substitution of Asp113 by alanine
did not modify the affinity of the mutated receptor for NT but reduced
its sensitivity for Na+ ions
(IC50 = 144 mM). Consequently, the affinity of
D113A-NTR1 for NT became insensitive to Na+ ions
concentrations, which are effective on the wild-type NTR1 (i.e., 17 mM). It is of interest to note that both mutant receptor (D113A-NTR1
and A79D-NTR2) are expressed at a lower level than their respective
wild types (Fig. 4). This indicates that single mutations in the second
spanning domain are sufficient to decrease receptor expression.
Surprisingly, GTP
S inhibited the binding of NT on homogenates from
cells transfected with this mutant NTR1 receptor with an efficiency
(IC50 = 3 nM) similar to that measured on the
wild-type receptor (Fig. 5). This led us to believe that the NTR1
belonged to the category of receptors such as the sst2A somatostatin
receptor (Kong et al., 1993a
), in which the mutation of the Asp residue
present in TM II did not alter receptor-G protein association. However,
the potency of NT to stimulate PI accumulation on COS-7 cells
transfected with the D113A-NTR1 mutant was actually dramatically
reduced (EC50 = 10.3 nM) as compared with the
wild-type (EC50 = 0.09 nM) (Fig. 6), indicating
that the association with G protein was effectively affected by the
loss of the negatively charged amino acid residue. These data show that
conclusions driven from the modulatory effects of GTP analogs on the
affinity of a ligand for its receptor should be interpreted with
caution when experimental results are obtained in acellular systems.
Although observation of a decrease in affinity probably reflects the
existence of an interaction between the receptor and a G protein, the
nonphysiological character of these experiments precludes their
interpretation on a quantitative basis. Thus, the 100-fold decrease in
potency of NT on the PI response resulting from the D113A mutation of the NTR1 (Fig. 6) could not be detected by measuring the
GTP
S-induced changes in NT binding properties of both receptors
(Fig. 5). Another possible explanation is that the discrepancy between
GTP
S effect and coupling efficiency could reflect a distinction
between determinants for the binding of the receptor to G proteins and
determinants for the activation of G proteins by the receptor. Thus,
Asp113 in the NTR1 would be necessary for G protein activation but not for G protein binding.
In conclusion, we showed that the presence of an Asp residue in the second TM domain of the two cloned NTRs is a necessary condition to observe sodium modulation of the NTR affinity. This same Asp residue is also involved in the coupling efficiency of the type 1 NT receptor to G proteins. However, mutation of the Asp residue does not abolish G protein coupling. The mode of interaction of the NTR1 with G proteins is therefore more similar to that of the sst2 receptor than to that of the alpha-2 and beta adrenergic receptors.
| |
Footnotes |
|---|
Received June 17, 1998; Accepted November 18, 1998
This work was supported by the Centre National de la Recherche Scientifique (CNRS). Jean-Marie Botto is a fellowship recipient of the Association pour la Recherche sur le Cancer.
Send reprint requests to: Dr. Jean Mazella, Institut de Pharmacologie Moléculaire et Cellulaire, Unité Propre de Recherche 411, Centre National de la Recherche Scientifique (CNRS), 660 route des Lucioles, 06560 Valbonne, France. E-mail: mazella{at}ipmc.cnrs.fr
| |
Abbreviations |
|---|
NT, neurotensin;
NTR1, neurotensin receptor
type 1;
NTR2, neurotensin receptor type 2;
PI, phosphoinositide(s);
GTP
S, guanosine-5'-O-(
-thio)triphosphate;
G
protein, guanine nucleotide-binding protein;
TM, transmembrane
domain.
| |
References |
|---|
|
|
|---|
2-adrenergic receptor-G-protein interactions.
J Biol Chem
269:
29557-29564
opioid receptor specifies selective high affinity agonist binding.
J Biol Chem
268:
23055-23058This article has been cited by other articles:
![]() |
L. Oliveira, C. M. Costa-Neto, C. R. Nakaie, S. Schreier, S. I. Shimuta, and A. C. M. Paiva The Angiotensin II AT1 Receptor Structure-Activity Correlations in the Light of Rhodopsin Structure Physiol Rev, April 1, 2007; 87(2): 565 - 592. [Abstract] [Full Text] [PDF] |
||||
![]() |
J H Li, F Sicard, M A Salam, M Baek, J LePrince, H Vaudry, K Kim, H B Kwon, and J Y Seong Molecular cloning and functional characterization of a type-I neurotensin receptor (NTR) and a novel NTR from the bullfrog brain J. Mol. Endocrinol., June 1, 2005; 34(3): 793 - 807. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. St-Gelais, M. Legault, M.-J. Bourque, P.-P. Rompre, and L.-E. Trudeau Role of Calcium in Neurotensin-Evoked Enhancement in Firing in Mesencephalic Dopamine Neurons J. Neurosci., March 10, 2004; 24(10): 2566 - 2574. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Luca, J. F. White, A. K. Sohal, D. V. Filippov, J. H. van Boom, R. Grisshammer, and M. Baldus The conformation of neurotensin bound to its G protein-coupled receptor PNAS, September 16, 2003; 100(19): 10706 - 10711. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-G. Gao, S.-K. Kim, A. S. Gross, A. Chen, J. B. Blaustein, and K. A. Jacobson Identification of Essential Residues Involved in the Allosteric Modulation of the Human A3 Adenosine Receptor Mol. Pharmacol., May 1, 2003; 63(5): 1021 - 1031. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Okada, Y. Fujiyoshi, M. Silow, J. Navarro, E. M. Landau, and Y. Shichida Functional role of internal water molecules in rhodopsin revealed by x-ray crystallography PNAS, April 30, 2002; 99(9): 5982 - 5987. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Richard, S. Barroso, J. Martinez, C. Labbe-Jullie, and P. Kitabgi Agonism, Inverse Agonism, and Neutral Antagonism at the Constitutively Active Human Neurotensin Receptor 2 Mol. Pharmacol., December 1, 2001; 60(6): 1392 - 1398. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Neve, M. G. Cumbay, K. R. Thompson, R. Yang, D. C. Buck, V. J. Watts, C. J. DuRand, and M. M. Teeter Modeling and Mutational Analysis of a Putative Sodium-Binding Pocket on the Dopamine D2 Receptor Mol. Pharmacol., August 1, 2001; 60(2): 373 - 381. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Okada, Y. Fujiyoshi, M. Silow, J. Navarro, E. M. Landau, and Y. Shichida Functional role of internal water molecules in rhodopsin revealed by x-ray crystallography PNAS, April 30, 2002; 99(9): 5982 - 5987. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||